NTA exceeds unsustainably low share price

With CDY's cash backing per share alone of more than twice its current price of $0.019, it is obvious the market is blind to the upside of this stock. Factor in that no value is presently reflected in the share price of either its fast growing Evolis hair care products business or its array of patents (Midkine etc) and Blind Freddie could see this company's fair value is a multiple of its present market cap. The independent research on Cellmid's website has that multiple at >4 times with an $0.08 ps valuation. Do the math